Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SW-BIC-213 COVID-19 mRNA Booster Vaccine Trial
NCT05580159Phase 3Unknown
- Sponsor
- Stemirna Therapeutics
- Start
- Oct 2022
- Primary completion
- May 2023
- Modality
- Nanoparticles, Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of SW-BIC-213 in coronavirus disease 2019 (COVID-19), sponsored by Stemirna Therapeutics. Status: unknown.
02
Drugs
SW-BIC-213
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05580159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05580159.